The protective role of zinc and N-acetylcysteine in modulating zidovudine induced hematopoietic toxicity
- 13 September 1996
- journal article
- Published by Elsevier in Life Sciences
- Vol. 59 (16) , 1323-1329
- https://doi.org/10.1016/0024-3205(96)00457-2
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Amelioration of zidovudine-induced fetal toxicity in pregnant miceAntimicrobial Agents and Chemotherapy, 1992
- Influence of interleukin‐3 on zidovudine (azt)‐induced in vitro toxicity to human hematopoietic progenitorsThe International Journal of Cell Cloning, 1992
- Recombinant Human Erythropoietin for Patients with AIDS Treated with ZidovudineNew England Journal of Medicine, 1990
- 2'-Deoxycytidine protects normal human bone marrow progenitor cells in vitro against the cytotoxicity of 3'-azido-3'-deoxythymidine with preservation of antiretroviral activityBlood, 1989
- Increased therapeutic efficacy of Zidovudine in combination with vitamin EBiochemical and Biophysical Research Communications, 1989
- Uridine reverses the toxicity of 3'-azido-3'-deoxythymidine in normal human granulocyte-macrophage progenitor cells in vitro without impairment of antiretroviral activityAntimicrobial Agents and Chemotherapy, 1988
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEXThe Lancet, 1986
- Trace elements: Biochemical and clinical effects of zinc and copperAmerican Journal of Hematology, 1979
- Interaction of zinc and lead on δ-aminolevulinate dehydrataseBiochemical and Biophysical Research Communications, 1975